Pharmaceutical
| Sun 22 Mar 2026
Munich, March 23 -- AstraZeneca AB has applied European patent for Methods of Treatment of Chronic Kidney Disease. Buvall Lisa, Dahlén Lars Anders, Karlsson Hans Fredrik, Zhou Alex Xianghua, Wallentin Hanna, Edman Karl Henrik, Geschwindner Stefan and Ormo Mats Fredrik developed it.
The patent application number is EP2024072584..